Diabetes Drug Actos May Cut Heart RiskDr. Theodore Mazzone, professor of medicine, is quoted in a WebMD story about his recently published research that found the diabetes drug Actos may slow the progression of cardiovascular disease in patients with type 2 diabetes.
|
University of Illinois Medical Center at Chicago © 2008 Notice of Privacy Practice | JCAHO Public Notice University of Illinois at Chicago | University of Illinois College of Medicine |